AtriCure (ATRC) Income from Continuing Operations (2010 - 2026)
AtriCure's (ATRC) quarterly Income from Continuing Operations came in at 108000.0 in Q1 2026, up 101.6% year-on-year from 53571.24 in Q1 2025, and down 93.85% on a QoQ basis from 1756000.0 in Q4 2025.
AtriCure (ATRC) Income from Continuing Operations (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has 17 years of Income from Continuing Operations data on file, last reported at 108000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 101.6% year-over-year to 108000.0 in Q1 2026; TTM through Mar 2026 was 4593000.0, a 87.97% increase from a year earlier, with the FY2025 full-year figure at 11448000.0, up 74.39% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 108000.0, down from 1756000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for ATRC reached as high as 1756000.0 in Q4 2025 and fell as low as 15568000.0 in Q4 2024.
- Historically, Income from Continuing Operations has averaged 7820117.65 across 5 years, with a median of 7853000.0 in 2024.
- Across the five-year window, Income from Continuing Operations sank 134.75% in 2023 and surged 111.28% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 4170000.0 in 2022, then sank by 134.75% to 9789000.0 in 2023, then sank by 59.04% to 15568000.0 in 2024, then jumped by 111.28% to 1756000.0 in 2025, then slumped by 93.85% to 108000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 108000.0 in Q1 2026, 1756000.0 in Q4 2025, and 267000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | AtriCure | 1.60 Bn | 1.45 Bn | 109.31 Mn | 108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | 1.76 Mn |
| Sep 30, 2025 | -267,000.00 |
| Jun 30, 2025 | -6.19 Mn |
| Mar 31, 2025 | -6.75 Mn |
| Dec 31, 2024 | -15.57 Mn |
| Sep 30, 2024 | -7.85 Mn |
| Jun 30, 2024 | -8.01 Mn |
| Mar 31, 2024 | -13.27 Mn |
| Dec 31, 2023 | -9.79 Mn |
| Sep 30, 2023 | -9.06 Mn |
| Jun 30, 2023 | -5.12 Mn |
| Mar 31, 2023 | -6.48 Mn |
| Dec 31, 2022 | -4.17 Mn |
| Sep 30, 2022 | -12.27 Mn |
| Jun 30, 2022 | -14.84 Mn |
| Mar 31, 2022 | -15.18 Mn |
| Dec 31, 2021 | -13.74 Mn |
| Sep 30, 2021 | 97.11 Mn |
| Jun 30, 2021 | -16.25 Mn |